Diode Laser Transscleral Cyclophotocoagulation for Refractory Glaucoma

Abstract

To evaluate the efficacy of contact diode laser transscleral cyclophotocoagulation using different treatment parameters. All eyes undergoing contact diode laser transscleral cyclophotocoagulation between April 1991 and September 1997 at our two institutions were enrolled. Success was defined as an intraocular pressure less than or equal to 22 mm Hg or absence of pain for poorly sighted and blind eyes. Two hundred six eyes of 204 patients (Salzburg, 117 eyes; New York, 89 eyes) were enrolled. Mean patient age was 65.8 ± 18.7 years (range, 4–96 years). Mean follow-up was 9.2 ± 11.2 months (range, 3–56 months). Mean preoperative and postoperative IOPs were 42.1 ± 11.0 mm Hg (range, 24–76 mm Hg) and 17.3 ± 10.9 mm Hg (P P Contact diode laser transscleral cyclophotocoagulation is useful in eyes with refractory glaucoma in which the risks of outflow surgery are deemed unacceptable.